BioNTech
we intend to expand and accelerate our pipeline development through a mix of targeted in licensing strategic collaborations and a ore | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2021
Slide
39 of 43
Related slides by other companies
AstraZeneca
Results
November 2021
oncology pipeline highlights | AstraZeneca
Boundless Bio
IPO
March 2024
amplified cancer cells have significantly elevated replication stress amplified amplified a | Boundless Bio
Immix Biopharma
Investor Presentation
March 2024
what is autologous chimeric antigen receptor car cell therapy patient specific genetic modification targeted therapy head insert gene for ree aes if a | Immix Biopharma
AbCellera
Results
May 2023
solving key challenges in developing cell engager cancer treatments controlling how cells are activated only targeting cancer cells ona | AbCellera
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io